A Phase 2, Randomized, Double-Blind, Placebo-Controlled,

Project: Research project

Project Details

Description

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of GS-6624 in Subjects with Idiopathic Pulmonary Fibrosis
StatusFinished
Effective start/end date2/22/1312/31/16

Funding

  • Gilead Sciences, Inc.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.